Long-Term Comparative Efficacy and Safety of Risdiplam and Nusinersen in Children with Type 1 Spinal Muscular Atrophy Authors (first, second and last of 8) Christos KokaliarisRachel EvansGautam Sajeev Content type: Original Research Open Access Published: 05 May 2024 Advances in Therapy Pages: 2414 - 2434
An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders Authors (first, second and last of 12) Nora Vanegas-ArroyaveStanley N. CaroffSamantha A. Cicero Content type: Current Opinion Open Access Published: 19 March 2024 CNS Drugs Pages: 239 - 254
Benzodiazepines for the Treatment of Seizure Clusters Authors (first, second and last of 5) Patricia E. PenovichVikram R. RaoAdrian L. Rabinowicz Content type: Review Article Open Access Published: 15 February 2024 CNS Drugs Pages: 125 - 140
Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records Authors (first, second and last of 18) Vicente VillanuevaCédric LaloyauxBernhard J. Steinhoff Content type: Original Research Article Open Access Published: 09 September 2023 CNS Drugs Pages: 819 - 835
The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment Authors (first, second and last of 16) Stephen L. HauserLudwig KapposPatrick Vermersch Content type: REVIEW Open Access Published: 14 July 2023 Neurology and Therapy Pages: 1491 - 1515
How I Treat Chronic Inflammatory Demyelinating Polyneuropathy Podcast Authors Urvi Desai Content type: COMMENTARY Open Access Published: 26 June 2023 Neurology and Therapy Pages: 1409 - 1417
Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis Authors (first, second and last of 10) Tuan VuAndreas MeiselJames F. Howard Jr. Content type: Summary of Research Open Access Published: 23 June 2023 Neurology and Therapy Pages: 1435 - 1438
Podcast on the Challenges and Recommendations to Address Unmet Needs in MS for LGBTQ+ Populations in the United States Authors William L. ConteMark CascioneAmy B. Sullivan Content type: COMMENTARY Open Access Published: 23 June 2023 Neurology and Therapy Pages: 1399 - 1407
Measuring Fatigue in Multiple Sclerosis: There may be Trouble Ahead Authors (first, second and last of 4) James CloseJo VandercappellenJeremy Hobart Content type: ORIGINAL RESEARCH Open Access Published: 23 June 2023 Neurology and Therapy Pages: 1649 - 1668
Summary of Research: Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ) Authors (first, second and last of 5) Stacie HudgensAndrea Phillips-BeyerHeike Benes Content type: Summary of Research Open Access Published: 26 April 2023 Advances in Therapy Pages: 2573 - 2576
Podcast on the Art of the Patient Conversation: Healthcare Provider Perspectives to Improve Outcomes in Multiple Sclerosis Authors Cortnee RomanDenise Bruen Content type: COMMENTARY Open Access Published: 09 March 2023 Neurology and Therapy Pages: 711 - 719
Comparative Effectiveness of Carbidopa/Levodopa Enteral Suspension and Deep Brain Stimulation on Pill Burden Reduction in Medicare Fee-for-Service Patients with Advanced Parkinson’s Disease Authors (first, second and last of 12) Michael J. SoileauFernando L. PaganMustafa S. Siddiqui Content type: ORIGINAL RESEARCH Open Access Published: 18 January 2023 Neurology and Therapy Pages: 459 - 478
Optic Nerve Sheath Fenestration for Progressive Visual Loss in Cerebral Venous Sinus Thrombosis: A Long-Term Retrospective Observational Study Authors (first, second and last of 13) Zongshan LiLu ChengHui Chen Content type: ORIGINAL RESEARCH Open Access Published: 07 January 2023 Neurology and Therapy Pages: 441 - 457
Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis Authors (first, second and last of 7) Brittney LagerJacob LisenoJames B. Lewin Content type: Original Research Open Access Published: 05 November 2022 Neurology and Therapy Pages: 145 - 159
Persistence, Adherence, and Switching to Higher-Cost Therapy in Patients with Multiple Sclerosis Initiating Oral Disease-Modifying Therapies: A Retrospective Real-World Study Authors (first, second and last of 5) Lita AraujoSvend S. GeertsenJanneke van Wingerden Content type: Original Research Open Access Published: 24 September 2022 Neurology and Therapy Pages: 1735 - 1748
Potential Unmet Needs in Acute Treatment of Migraine in Japan: Results of the OVERCOME (Japan) Study Authors (first, second and last of 8) Takao TakeshimaKaname UedaKoichi Hirata Content type: Original Research Open Access Published: 12 September 2022 Advances in Therapy Pages: 5176 - 5190
Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations Authors (first, second and last of 7) Michael C. SmithPavel KleinWilliam E. Rosenfeld Content type: Original Research Open Access Published: 03 September 2022 Neurology and Therapy Pages: 1705 - 1720
Benzodiazepines in the Management of Seizures and Status Epilepticus: A Review of Routes of Delivery, Pharmacokinetics, Efficacy, and Tolerability Authors (first, second and last of 14) Ricardo KienitzLara KayLaurent M. Willems Content type: Review Article Open Access Published: 16 August 2022 CNS Drugs Pages: 951 - 975
Three Newly Recognized Likely Pathogenic Gene Variants Associated with Hereditary Transthyretin Amyloidosis Authors (first, second and last of 8) Jignesh K. PatelAndrew M. RosenArvind Narayana Content type: Original Research Open Access Published: 06 August 2022 Neurology and Therapy Pages: 1595 - 1607
The Association Between the Occurrence of Common Treatment-Emergent Adverse Events and Efficacy Outcomes After Lasmiditan Treatment of a Single Migraine Attack: Secondary Analyses from Four Pooled Randomized Clinical Trials Authors (first, second and last of 7) Erin G. DotyPaula M. HauckRichard B. Lipton Content type: Original Research Article Open Access Published: 02 July 2022 CNS Drugs Pages: 771 - 783
A Targeted Literature Search and Phenomenological Review of Perspectives of People with Multiple Sclerosis and Healthcare Professionals of the Immunology of Disease-Modifying Therapies Authors (first, second and last of 12) Jeri BurtchellDaisy ClemmonsAhmed Z. Obeidat Content type: Review Open Access Published: 24 May 2022 Neurology and Therapy Pages: 955 - 979
Health-Related Quality of Life with Diroximel Fumarate in Patients with Relapsing Forms of Multiple Sclerosis: Findings from Qualitative Research Using Patient Interviews Authors (first, second and last of 8) Mark GudesblattCortnee RomanShivani Kapadia Content type: Original Research Open Access Published: 13 May 2022 Advances in Therapy Pages: 3199 - 3213
Assessment and Management of Cognitive Function in Patients with Prostate Cancer Treated with Second-Generation Androgen Receptor Pathway Inhibitors Authors (first, second and last of 5) Jeffrey S. WefelCharles J. RyanAlicia K. Morgans Content type: Review Article Open Access Published: 06 May 2022 CNS Drugs Pages: 419 - 449
Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study Authors (first, second and last of 17) Sibyl WrayFlorian Then BerghBarry A. Singer Content type: Original Research Open Access Published: 24 February 2022 Advances in Therapy Pages: 1810 - 1831
A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication Authors Adam StrzelczykSusanne Schubert-Bast Content type: Therapy in Practice Open Access Published: 14 February 2022 CNS Drugs Pages: 217 - 237
Podcast on B Cell-Targeting Therapies and Other Multiple Sclerosis Concerns During COVID-19 Authors Robert K. ShinPavle RepovicJoseph R. Berger Content type: Commentary Open Access Published: 23 January 2022 Neurology and Therapy Pages: 515 - 524
Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder Authors (first, second and last of 10) Dean M. WingerchukIna ZhangSean J. Pittock Content type: Original Research Open Access Published: 13 November 2021 Neurology and Therapy Pages: 123 - 135
The Lived Experience of Myasthenia Gravis: A Patient-Led Analysis Authors (first, second and last of 5) Nancy LawKelly DavioKenza Seddik Content type: Original Research Open Access Published: 23 October 2021 Neurology and Therapy Pages: 1103 - 1125
AbobotulinumtoxinA Versus OnabotulinumtoxinA in Adults with Upper Limb Spasticity: A Randomized, Double-Blind, Crossover Study Protocol Authors (first, second and last of 6) Alberto EsquenaziZiyad AyyoubAtul T. Patel Content type: Study Protocol Open Access Published: 25 September 2021 Advances in Therapy Pages: 5623 - 5633
Management of Neurogenic Orthostatic Hypotension in Neurodegenerative Disorders: A Collaboration Between Cardiology and Neurology Authors Fahd S. AmjadSean C. Beinart Content type: Commentary Open Access Published: 07 September 2021 Neurology and Therapy Pages: 427 - 434
Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating Suvorexant Authors (first, second and last of 7) Hrishikesh P. KaleZaina P. QureshiRuth Benca Content type: Original Research Open Access Published: 31 August 2021 Advances in Therapy Pages: 5221 - 5237
Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine Authors Dan J. Stein Content type: Review Open Access Published: 21 August 2021 Advances in Therapy Pages: 52 - 60
Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis Authors (first, second and last of 5) Amit Bar-OrSusan M. O’BrienJeffrey A. Cohen Content type: Review Article Open Access Published: 09 August 2021 CNS Drugs Pages: 985 - 997
Early Data on Long-term Impact of Inotersen on Quality-of-Life in Patients with Hereditary Transthyretin Amyloidosis Polyneuropathy: Open-Label Extension of NEURO-TTR Authors (first, second and last of 10) Aaron YarlasAndrew LovleyMárcia Waddington-Cruz Content type: Original Research Open Access Published: 05 August 2021 Neurology and Therapy Pages: 865 - 886
Expert Perspectives on COVID-19 Vaccination for People Living with Multiple Sclerosis Authors Robert K. ShinKottil W. RammohanMitzi J. Williams Content type: Commentary Open Access Published: 04 August 2021 Neurology and Therapy Pages: 415 - 425
Exploring the Evidence for Broad-Spectrum Effectiveness of Perampanel: A Systematic Review of Clinical Data in Generalised Seizures Authors (first, second and last of 8) Eugen TrinkaSimona LattanziFrancesco Brigo Content type: Systematic Review Open Access Published: 07 July 2021 CNS Drugs Pages: 821 - 837
Hypervigilance, Allostatic Load, and Migraine Prevention: Antibodies to CGRP or Receptor Authors (first, second and last of 6) Andrew BlumenfeldPaul L. DurhamIra Turner Content type: Review Open Access Published: 02 June 2021 Neurology and Therapy Pages: 469 - 497
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on ‘Off’-time in Patients with Advanced Parkinson’s Disease: A Systematic Review Authors (first, second and last of 11) Angelo AntoniniPer OdinK. Ray Chaudhuri Content type: Review Open Access Published: 20 May 2021 Advances in Therapy Pages: 2854 - 2890
Patient and Provider Insights into the Impact of Multiple Sclerosis on Mental Health: A Narrative Review Authors (first, second and last of 5) Bryan E. DavisLynsey LakinMary R. Rensel Content type: Review Open Access Published: 20 April 2021 Neurology and Therapy Pages: 99 - 119
Comprehensive Approach to Management of Multiple Sclerosis: Addressing Invisible Symptoms—A Narrative Review Authors (first, second and last of 5) Lynsey LakinBryan E. DavisMary R. Rensel Content type: Review Open Access Published: 20 April 2021 Neurology and Therapy Pages: 75 - 98
Multiple Sclerosis Patients Treated With Diroximel Fumarate in the Real-World Setting Have High Rates of Persistence and Adherence Authors (first, second and last of 6) Jacob LisenoBrittney LagerJames B. Lewin Content type: Brief Report Open Access Published: 12 April 2021 Neurology and Therapy Pages: 349 - 360
Treatment Satisfaction of Galcanezumab in Japanese Patients with Episodic Migraine: A Phase 2 Randomized Controlled Study Authors (first, second and last of 4) Yoshihisa TatsuokaTakao TakeshimaTaka Matsumura Content type: Original Research Open Access Published: 09 April 2021 Neurology and Therapy Pages: 265 - 278
Efficacy of Agomelatine 25–50 mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled Studies Authors (first, second and last of 5) Dan J. SteinJon-Paul KhooMichael Van Ameringen Content type: Original Research Open Access Published: 04 February 2021 Advances in Therapy Pages: 1567 - 1583
OnabotulinumtoxinA in Chronic Migraine: A Profile of Its Use Authors James E. Frampton Content type: Adis Drug Q&A Open Access Published: 11 December 2020 CNS Drugs Pages: 1287 - 1298
Neurogenic Orthostatic Hypotension in Parkinson Disease: A Primer Authors Jeremy K. Cutsforth-GregoryPhillip A. Low Content type: Review Open Access Published: 27 August 2019 Neurology and Therapy Pages: 307 - 324